Clinical Trial Detail

NCT ID NCT01939223
Title COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo?Controlled Phase-III STudy (COAST)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements no
Sponsors Bayer
Indications

rectum adenocarcinoma

colorectal cancer

colon adenocarcinoma

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.